nach oben

Erschienen in:

19.01.2019 | Original Article

Erythropoietin protects the subventricular zone and inhibits reactive astrogliosis in kaolin-induced hydrocephalic rats

verfasst von: Wihasto Suryaningtyas, Muhammad Arifin, Fedik Abdul Rantam, Abdul Hafid Bajamal, Yoes Prijatna Dahlan, I Dewa Gede Ugrasena, Sri Maliawan

Erschienen in: Child's Nervous System | Ausgabe 3/2019

Einloggen, um Zugang zu erhalten

Abstract

Purpose

To elucidate the potential role of erythropoietin (EPO) as a neuroprotective agent against reactive astrogliosis and reducing the thinning rate of subventricular zone (SVZ) in kaolin-induced hydrocephalic rats.

Method

Thirty-six ten-week-old Sprague-Dawley rats were used in this study. Hydrocephalus was induced with 20% kaolin suspension injected into the cistern of thirty rats and leaving the six rats as normal group. The hydrocephalic rats were randomly divided into hydrocephalic and treatment group. The treatment group received daily dose of recombinant human erythropoietin (rhEPO) from day 7 to day 21 after induction. The animals were sacrificed at 7 (only for hydrocephalic group) and 14 or 21 (for both groups) days after induction. Brain was removed and was prepared for histological analysis by hematoxylin and eosin staining as well as immunohistochemistry for 4-HNE, GFAP, Iba-1, and Ki-67.

Results

Histopathological analysis showed that animals treated with rhEPO had a reduced astrocyte reactivity displayed by lower GFAP expression. Hydrocephalic rats received rhEPO also displayed reduced microglial activation shown by lower Iba-1 protein expression. Exogenous rhEPO exerted its protective action in reducing astrogliosis by inhibiting lipid peroxidation that was documented in this study as lower expression of 4-HNE than non-treated group. The SVZ thickness was progressively declining in hydrocephalus group, while the progression rate could be reduced by rhEPO.

Conclusion

Erythropoietin has a potential use for inhibiting lipid peroxidation, and reactive astrogliosis in hydrocephalic animal model. The reduced thinning rate of SVZ demonstrated that EPO also had effect in reducing the hydrocephalus progressivity. Further research is warranted to explore its efficacy and safety to use in clinical setting.

Deren KE, Packer M, Forsyth J, Milash B, Abdullah OM, Hsu EW, McAllister JP II (2010) Reactive astrocytosis, microgliosis and inflammation in rats with neonatal hydrocephalus. Exp Neurol 226:110–119. https://doi.org/10.1016/j.expneurol.2010.08.010 PubMedCrossRef

Miller JM, McAllister JP (2007) Reduction of astrogliosis and microgliosis by cerebrospinal fluid shunting in experimental hydrocephalus. Cerebrospinal Fluid Res 4:1–14. https://doi.org/10.1186/1743-8454-4-5 CrossRef

Sofroniew MV (2009) Molecular dissection of reactive astrogliosis and glial scar formation. Trends Neurosci 32:638–647. https://doi.org/10.1016/j.tins.2009.08.002 PubMedPubMedCentralCrossRef

Eskandari R, Harris CA, McAllister JP (2011) Reactive astrocytosis in feline neonatal hydrocephalus: acute, chronic, and shunt-induced changes. Childs Nerv Syst 27:2067–2076. https://doi.org/10.1007/s00381-011-1552-4 PubMedCrossRef

Campos-Ordoñez T, Herranz-Pérez V, Chaichana KL, Rincon-Torroella J, Rigamonti D, García-Verdugo JM, Quiñones-Hinojosa A, Gonzalez-Perez O (2014) Long-term hydrocephalus alters the cytoarchitecture of the adult subventricular zone. Exp Neurol 261:236–244. https://doi.org/10.1016/j.expneurol.2014.05.011 PubMedCrossRef

Di Curzio DL, Buist RJ, Del Bigio MR (2013) Reduced subventricular zone proliferation and white matter damage in juvenile ferrets with kaolin-induced hydrocephalus. Exp Neurol 248:112–128. https://doi.org/10.1016/j.expneurol.2013.06.004 PubMedCrossRef

Li Y, Wu D, Wu C, Qu Z, Zhao Y, Li W, Wang J, Li Z (2014) Changes in neural stem cells in the subventricular zone in a rat model of communicating hydrocephalus. Neurosci Lett 578:153–158. https://doi.org/10.1016/j.neulet.2014.06.053 PubMedCrossRef

Del Bigio MR, Di Curzio DL (2015) Nonsurgical therapy for hydrocephalus: a comprehensive and critical review. Fluids Barriers CNS 13:3. https://doi.org/10.1186/s12987-016-0025-2 CrossRef

Ott C, Martens H, Hassouna I, Oliveira B, Erck C, Zafeiriou MP, Peteri UK, Hesse D, Gerhart S, Altas B, Kolbow T, Stadler H, Kawabe H, Zimmermann WH, Nave KA, Schulz-Schaeffer W, Jahn O, Ehrenreich H (2015) Widespread expression of erythropoietin receptor in brain and its induction by injury. Mol Med 21:803–815. https://doi.org/10.2119/molmed.2015.00192 PubMedPubMedCentralCrossRef

10.

Nagai A, Nakagawa E, Choi HB, Hatori K, Kobayashi S, Kim SU (2001) Erythropoietin and erythropoietin receptors in human CNS neurons, astrocytes, microglia, and oligodendrocytes grown in culture. J Neuropathol Exp Neurol 60:386–392. https://doi.org/10.1093/jnen/60.4.386 PubMedCrossRef

11.

Khan OH, Del Bigio MR (2006) Experimental models of hydrocephalus. In: Tatlisumak T, Fisher M (eds) Handb. Exp. Neurol. Methods Tech. Anim. Res. Cambridge University Press, Cambridge, UK, pp 457–471CrossRef

12.

Kaemmerer D, Peter L, Lupp A, Schulz S, Sänger J, Baum RP, Prasad V, Hommann M (2012) Comparing of IRS and Her2 as immunohistochemical scoring schemes in gastroenteropancreatic neuroendocrine tumors. Int J Clin Exp Pathol 5:187–194PubMedPubMedCentral

13.

Hochwald GM, Lux WE, Sahar A, Ransohoff J (1972) Experimental hydrocephalus: changes in cerebrospinal fluid dynamics as a function of time. Arch Neurol 26:120–129PubMedCrossRef

14.

Kim MJ, Hwang SK, Hwang JH et al (2000) Sequential 1 H MR spectroscopy MRS studies of kaolin-induced hydrocephalic cat brain. J Korean Neurosurg Soc 29:1421–1428

15.

Xu H, Xu B, Wang ZX, Tan GW, Shen SH (2015) Inhibition of Wnt/β-catenin signal is alleviated reactive gliosis in rats with hydrocephalus. Childs Nerv Syst 31:227–234. https://doi.org/10.1007/s00381-014-2613-2 PubMedCrossRef

16.

Minnerup J, Heidrich J, Rogalewski A, Schäbitz WR̈, Wellmann J̈ (2009) The efficacy of erythropoietin and its analogues in animal stroke models: a meta-analysis. Stroke 40:3113–3120. https://doi.org/10.1161/STROKEAHA.109.555789 PubMedCrossRef

17.

Shi X, Yang J, Zhu H, Ye L, Feng M, Li J, Huang H, Tao Q, Ye D, Sun LHK, Sun BNC, Sun CRY, Han G, Liu Y, Yao M, Zhou P, Ju D (2013) Pharmacokinetics and pharmacodynamics of recombinant human EPO-Fc fusion protein in vivo. PLoS One 8:e72673. https://doi.org/10.1371/journal.pone.0072673 PubMedPubMedCentralCrossRef

18.

Domínguez-Pinos MD, Páez P, Jiménez AJ, Weil B, Arráez MA, Pérez-Fígares J´M, Rodríguez EM (2005) Ependymal denudation and alterations of the subventricular zone occur in human fetuses with a moderate communicating hydrocephalus. J Neuropathol Exp Neurol 64:595–604. https://doi.org/10.1097/01.jnen.0000171648.86718.bb PubMedCrossRef

19.

Da Silva MC, Michowicz S, Drake JM et al (1995) Reduced local cerebral blood flow in periventricular white matter in experimental neonatal hydrocephalus-restoration with CSF shunting. J Cereb Blood Flow Metab 15:1057–1065. https://doi.org/10.1038/jcbfm.1995.132 PubMedCrossRef

20.

Momjian S, Owler BK, Czosnyka Z, Czosnyka M, Pena A, Pickard JD (2004) Pattern of white matter regional cerebral blood flow and autoregulation in normal pressure hydrocephalus. Brain 127:965–972. https://doi.org/10.1093/brain/awh131 PubMedCrossRef

21.

Del Bigio MR, Bruni JE (1988) Changes in periventricular vasculature of rabbit brain following induction of hydrocephalus and after shunting. J Neurosurg 69:115–120. https://doi.org/10.3171/jns.1988.69.1.0115 PubMedCrossRef

22.

Rosenberg GA, Saland L, Kyner WT (1983) Pathophysiology of periventricular tissue changes with raised CSF pressure in cats. J Neurosurg 59:606–611. https://doi.org/10.3171/jns.1983.59.4.0606 PubMedCrossRef

23.

Del BMR, Khan OH, Lopes S, Juliet PAR (2012) Cerebral white matter oxidation and nitrosylation in young rodents with kaolin-induced hydrocephalus. J Neuropathol Exp Neurol 71:274–288CrossRef

24.

Caner H, Atasever A, Kilinç K et al (1993) Lipid peroxide level increase in experimental hydrocephalus. Acta Neurochir 121:68–71. https://doi.org/10.1007/BF01405185 PubMedCrossRef

25.

Calapai G, Marciano MC, Corica F, Allegra A, Parisi A, Frisina N, Caputi AP, Buemi M (2000) Erythropoietin protects against brain ischemic injury by inhibition of nitric oxide formation. Eur J Pharmacol 401:349–356. https://doi.org/10.1016/S0014-2999(00)00466-0 PubMedCrossRef

26.

Aras M, Urfali B, Serarslan Y et al (2014) Protective effects of minocycline against short-term ischemia-reperfusion injury in rat brain. Pediatr Neurosurg 49:172–178. https://doi.org/10.1159/000362202 CrossRef

27.

Ayala A, Muñoz MF, Argüelles S (2014) Lipid peroxidation: production, metabolism, and signaling mechanisms of malondialdehyde and 4-hydroxy-2-nonenal. Oxidative Med Cell Longev 2014:1–31. https://doi.org/10.1155/2014/360438 CrossRef

28.

Chattopadhyay A, Das Choudhury T, Bandyopadhyay D, Datta AG (2000) Protective effect of erythropoietin on the oxidative damage of erythrocyte membrane by hydroxyl radical. Biochem Pharmacol 59:419–425. https://doi.org/10.1016/S0006-2952(99)00277-4 PubMedCrossRef

29.

Kumral A, Gonenc S, Acikgoz O, Sonmez A, Genc K, Yilmaz O, Gokmen N, Duman N, Ozkan H (2005) Erythropoietin increases glutathione peroxidase enzyme activity and decreases lipid peroxidation levels in hypoxic-ischemic brain injury in neonatal rats. Biol Neonate 87:15–18. https://doi.org/10.1159/000080490 PubMedCrossRef

30.

Hu X, Li P, Guo Y, Wang H, Leak RK, Chen S, Gao Y, Chen J (2012) Microglia/macrophage polarization dynamics reveal novel mechanism of injury expansion after focal cerebral ischemia. Stroke 43:3063–3070. https://doi.org/10.1161/STROKEAHA.112.659656 PubMedCrossRef

31.

Liddelow SA, Guttenplan KA, Clarke LE, Bennett FC, Bohlen CJ, Schirmer L, Bennett ML, Münch AE, Chung WS, Peterson TC, Wilton DK, Frouin A, Napier BA, Panicker N, Kumar M, Buckwalter MS, Rowitch DH, Dawson VL, Dawson TM, Stevens B, Barres BA (2017) Neurotoxic reactive astrocytes are induced by activated microglia. Nature 541:481–487. https://doi.org/10.1038/nature21029 PubMedPubMedCentralCrossRef

32.

Liddelow SA, Barres BA (2017) Reactive astrocytes: production, function, and therapeutic potential. Immunity 46:957–967. https://doi.org/10.1016/j.immuni.2017.06.006 PubMedCrossRef

33.

Wang Y, Cheng X, He Q, Zheng Y, Kim DH, Whittemore SR, Cao QL (2011) Astrocytes from the contused spinal cord inhibit oligodendrocyte differentiation of adult oligodendrocyte precursor cells by increasing the expression of bone morphogenetic proteins. J Neurosci 31:6053–6058. https://doi.org/10.1523/JNEUROSCI.5524-09.2011 PubMedPubMedCentralCrossRef

34.

Siebert JR, Conta Steencken A, Osterhout DJ (2014) Chondroitin sulfate proteoglycans in the nervous system: inhibitors to repair. Biomed Res Int 2014:1–15. https://doi.org/10.1155/2014/845323 CrossRef

35.

Deng YP, Sun Y, Hu L, Li ZH, Xu QM, Pei YL, Huang ZH, Yang ZG, Chen C (2015) Chondroitin sulfate proteoglycans impede myelination by oligodendrocytes after perinatal white matter injury. Exp Neurol 269:213–223. https://doi.org/10.1016/j.expneurol.2015.03.026 PubMedCrossRef

36.

Eskandari R, Packer M, Burdett EC, McAllister JP (2012) Effect of delayed intermittent ventricular drainage on ventriculomegaly and neurological deficits in experimental neonatal hydrocephalus. Childs Nerv Syst 28:1849–1861. https://doi.org/10.1007/s00381-012-1848-z PubMedCrossRef

37.

Di Curzio DL, Turner-Brannen E, Del Bigio MR (2014) Oral antioxidant therapy for juvenile rats with kaolin-induced hydrocephalus. Fluids Barriers CNS 11:1–10. https://doi.org/10.1186/2045-8118-11-23 CrossRef

38.

Velly L, Pellegrini L, Guillet B, Bruder N, Pisano P (2010) Erythropoietin 2nd cerebral protection after acute injuries: a double-edged sword? Pharmacol Ther 128:445–459. https://doi.org/10.1016/j.pharmthera.2010.08.002 PubMedCrossRef

39.

Rizwan Siddiqui M, Attar F, Mohanty V, Kim KS, Shekhar Mayanil C, Tomita T (2018) Erythropoietin-mediated activation of aquaporin-4 channel for the treatment of experimental hydrocephalus. Childs Nerv Syst 34:2195–2202. https://doi.org/10.1007/s00381-018-3865-z PubMedPubMedCentralCrossRef

40.

Robinson S, Conteh FS, Oppong AY, Yellowhair TR, Newville JC, Demerdash NE, Shrock CL, Maxwell JR, Jett S, Northington FJ, Jantzie LL (2018) Extended combined neonatal treatment with erythropoietin plus melatonin prevents posthemorrhagic hydrocephalus of prematurity in rats. Front Cell Neurosci 12:1–20. https://doi.org/10.3389/fncel.2018.00322 CrossRef

41.

Xia CY, Zhang S, Gao Y, Wang ZZ, Chen NH (2015) Selective modulation of microglia polarization to M2 phenotype for stroke treatment. Int Immunopharmacol 25:377–382. https://doi.org/10.1016/j.intimp.2015.02.019 PubMedCrossRef

42.

Alvarez-Buylla A, Lim DA (2004) For the long run: maintaining germinal niches in the adult brain. Neuron 41:683–686. https://doi.org/10.1016/S0896-6273(04)00111-4 PubMedCrossRef

43.

Gonzalez-Perez O, Alvarez-Buylla A (2011) Oligodendrogenesis in the subventricular zone and the role of epidermal growth factor. Brain Res Rev 67:147–156. https://doi.org/10.1016/j.brainresrev.2011.01.001 PubMedPubMedCentralCrossRef

44.

Brazel CY, Romanko MJ, Rothstein RP, Levison SW (2003) Roles of the mammalian subventricular zone in brain development. Prog Neurobiol 69:49–69. https://doi.org/10.1016/S0301-0082(03)00002-9 PubMedCrossRef

45.

Martínez-Cerdeño V, Cunningham CL, Camacho J, Antczak JL, Prakash AN, Cziep ME, Walker AI, Noctor SC (2012) Comparative analysis of the subventricular zone in rat, ferret and macaque: evidence for an outer subventricular zone in rodents. PLoS One 7:e30178. https://doi.org/10.1371/journal.pone.0030178 PubMedPubMedCentralCrossRef

46.

Palma-Tortosa S, García-Culebras A, Moraga A, Hurtado O, Perez-Ruiz A, Durán-Laforet V, Parra J, Cuartero MI, Pradillo JM, Moro MA, Lizasoain I (2017) Specific features of SVZ neurogenesis after cortical ischemia: a longitudinal study. Sci Rep 7:1–12. https://doi.org/10.1038/s41598-017-16109-7 CrossRef

47.

Kaneko N, Kako E, Sawamoto K (2013) Enhancement of ventricular-subventricular zone-derived neurogenesis and oligodendrogenesis by erythropoietin and its derivatives. Front Cell Neurosci 7:1–11. https://doi.org/10.3389/fncel.2013.00235 CrossRef

48.

Gonzalez-Perez O, Gutierrez-Fernandez F, Lopez-Virgen V, Collas-Aguilar J, Quinones-Hinojosa A, Garcia-Verdugo JM (2012) Immunological regulation of neurogenic niches in the adult brain. Neuroscience 226:270–281. https://doi.org/10.1016/j.neuroscience.2012.08.053 PubMedPubMedCentralCrossRef

Titel: Erythropoietin protects the subventricular zone and inhibits reactive astrogliosis in kaolin-induced hydrocephalic rats
verfasst von: Wihasto Suryaningtyas
Muhammad Arifin
Fedik Abdul Rantam
Abdul Hafid Bajamal
Yoes Prijatna Dahlan
I Dewa Gede Ugrasena
Sri Maliawan
Publikationsdatum: 19.01.2019
Verlag: Springer Berlin Heidelberg
Erschienen in: Child's Nervous System / Ausgabe 3/2019
Print ISSN: 0256-7040
Elektronische ISSN: 1433-0350
DOI: https://doi.org/10.1007/s00381-019-04063-w

Neu im Fachgebiet Chirurgie

23.04.2024 | Ablationstherapie | Nachrichten

Wie erfolgreich ist eine Re-Ablation nach Rezidiv?

23.04.2024 | Appendizitis | Nachrichten

Hinter dieser Appendizitis steckte ein Erreger

23.04.2024 | Operationsvorbereitung | Nachrichten

Mehr Schaden als Nutzen durch präoperatives Aussetzen von GLP-1-Agonisten?

19.04.2024 | EAU 2024 | Kongressbericht | Nachrichten

Ureterstriktur: Innovative OP-Technik bewährt sich

weitere anzeigen

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Aktuelle BDC Leitlinien-Webinare

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare

CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare

CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske

Dr. med. Benjamin Meyknecht

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare

CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric

Springer Medizin

Abstract

Purpose

Method

Results

Conclusion

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 3/2019

Lack of association of cranial lacunae with intracranial hypertension in children with Crouzon syndrome and Apert syndrome: a 3D morphometric quantitative analysis

Neurocognitive, academic and functional outcomes in survivors of infant ependymoma (UKCCSG CNS 9204)

Our understanding and treatment of childhood hydrocephalus circa 1890 via Keating’s Cyclopaedia of the Diseases of Children

Neurocognitive profile in children with arachnoid cysts before and after surgical intervention

Surgical considerations in a paediatric case of a large skull-base epithelioid haemangioendothelioma

Primary intracranial extraosseous Ewing’s sarcoma

Neu im Fachgebiet Chirurgie

Wie erfolgreich ist eine Re-Ablation nach Rezidiv?

Hinter dieser Appendizitis steckte ein Erreger

Mehr Schaden als Nutzen durch präoperatives Aussetzen von GLP-1-Agonisten?

Ureterstriktur: Innovative OP-Technik bewährt sich

Update Chirurgie

Aktuelle BDC Leitlinien-Webinare

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

S2e-Leitlinie „Distale Radiusfraktur“

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“